Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Fisher & Paykel Healthcare Corp Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $13.57 billion
P/E Ratio 54.16
Dividend Yield 1.46%
Shares Outstanding 582.17 million
Earnings per share 0.449
Dividend per share 0.33
Year To Date Return 4.58%
Earnings Yield 1.85%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
    Latest News

    Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares
    Share Market News

    Here's how the ASX 200 market sectors stacked up this week

    The ASX 200 gained 0.36% in the first week of the earnings season, finishing at 7,644.8 points on Friday.

    Read more »

    A woman's hand draws a stylised 'Top Ten' on a projected surface.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a brutal return to earth for ASX 200 shares today.

    Read more »

    Person with a handful of Australian dollar notes, symbolising dividends.
    Dividend Investing

    Which ASX 200 healthcare share will pay the best dividend yield in FY24?

    Healthcare stocks are a traditional defensive play in challenging economic times.

    Read more »

    A man holds up a block from falling in a row of dominos.
    Share Market News

    Here's how the ASX 200 market sectors stacked up this week

    The ASX 200 gained 0.36% and the technology sector stood out.

    Read more »

    A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
    Dividend Investing

    3 ASX All Ords shares with ex-dividend dates next week

    You'll need to get a wriggle on if you want to receive these dividends.

    Read more »

    A woman with a broad smile on her face holds up ten fingers.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was another happy day for most ASX 200 shares this Wednesday.

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Evolution, Fisher & Paykel, IDP Education, and Temple & Webster shares are jumping

    These ASX shares are having a strong session on hump day. But why?

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Here's why this ASX 200 healthcare stock is roaring 13% higher on Wednesday

    This healthcare company is outperforming every other stock within the ASX 200 today.

    Read more »

    A senior couple discusses a share trade they are making on a laptop computer
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was another horror show on the ASX 200 today.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 had a horror start to the trading week today.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was a woeful Wednesday for ASX shares today.

    Read more »

    A woman's hand draws a stylised 'Top Ten' on a projected surface.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was a bloodbath on the ASX boards today...

    Read more »

    Frequently Asked Questions

    Yes, Fisher & Paykel Healthcare has historically paid two unfranked shareholder dividends a year.

    Fisher & Paykel Healthcare generally pays its shareholder dividends in July and December.

    Yes, Fisher & Paykel Healthcare has a dividend reinvestment plan which allows eligible shareholders in New Zealand, Australia, and the United Kingdom to reinvest all or part of their cash dividends in additional ordinary shares free of brokerage fees.

    Yes, Fisher & Paykel Healthcare Corporation Ltd is listed on the ASX and the New Zealand Exchange.

    Fisher & Paykel Healthcare Corporation Ltd listed on the ASX on 21 November 2001.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    05 Dec 2023 $0.0318 0.00% Supplemental 18 Dec 2023
    05 Dec 2023 $0.1800 0.00% Interim 18 Dec 2023
    26 Jun 2023 $0.0406 0.00% Supplemental 07 Jul 2023
    26 Jun 2023 $0.2117 0.00% Interim 07 Jul 2023
    08 Dec 2022 $0.0309 0.00% Supplemental 21 Dec 2022
    08 Dec 2022 $0.1645 0.00% Interim 21 Dec 2022
    22 Jun 2022 $0.0397 0.00% Supplemental 06 Jul 2022
    22 Jun 2022 $0.2029 0.00% Final 06 Jul 2022
    02 Dec 2021 $0.0300 0.00% Supplemental 15 Dec 2021
    02 Dec 2021 $0.1784 0.00% Interim 15 Dec 2021
    24 Jun 2021 $0.0388 0.00% Supplemental 07 Jul 2021
    24 Jun 2021 $0.2046 0.00% Final 07 Jul 2021
    03 Dec 2020 $0.0282 0.00% Supplemental 16 Dec 2020
    03 Dec 2020 $0.1510 0.00% Interim 16 Dec 2020
    06 Jul 2020 $0.0274 0.00% Supplemental 17 Jul 2020
    06 Jul 2020 $0.1463 0.00% Final 17 Jul 2020
    06 Dec 2019 $0.0212 0.00% Supplemental 19 Dec 2019
    06 Dec 2019 $0.1148 0.00% Interim 19 Dec 2019
    13 Jun 2019 $0.1287 0.00% Final 05 Jul 2019
    07 Dec 2018 $0.0172 0.00% Supplemental 21 Dec 2018
    07 Dec 2018 $0.0921 0.00% Interim 21 Dec 2018
    21 Jun 2018 $0.0221 0.00% Supplemental 06 Jul 2018
    21 Jun 2018 $0.1151 0.00% Final 06 Jul 2018
    05 Dec 2017 $0.0154 0.00% Supplemental 20 Dec 2017
    05 Dec 2017 $0.7802 0.00% Interim 20 Dec 2017
    15 Jun 2017 $0.0199 0.00% Supplemental 07 Jul 2017
    15 Jun 2017 $0.1074 0.00% Final 07 Jul 2017
    06 Dec 2016 $0.0789 0.00% Interim 21 Dec 2016
    16 Jun 2016 $0.0955 0.00% Final 08 Jul 2016
    09 Dec 2015 $0.0629 0.00% Interim 23 Dec 2015
    17 Jun 2015 $0.0710 0.00% Final 10 Jul 2015
    03 Dec 2014 $0.0537 0.00% Interim 19 Dec 2014
    18 Jun 2014 $0.0650 0.00% Final 04 Jul 2014
    04 Dec 2013 $0.0491 0.00% Interim 19 Dec 2013
    19 Jun 2013 $0.0586 0.00% Final 05 Jul 2013
    29 Nov 2012 $0.0426 0.00% Interim 14 Dec 2012
    20 Jun 2012 $0.0550 0.00% Final 06 Jul 2012
    30 Nov 2011 $0.0413 0.00% Interim 16 Dec 2011
    22 Jun 2011 $0.0534 0.00% Final 08 Jul 2011
    01 Dec 2010 $0.0418 0.00% Interim 17 Dec 2010
    28 Jun 2010 $0.0000 0.00% Final 09 Jul 2010
    10 Dec 2009 $0.0301 0.00% Interim 18 Dec 2009
    22 Jun 2009 $0.0476 0.00% Final 06 Jul 2009
    04 Dec 2008 $0.0095 0.00% Supplemental 12 Dec 2008
    04 Dec 2008 $0.0000 0.00% Interim 12 Dec 2008
    19 Jun 2008 $0.0062 0.00% Supplemental 27 Jun 2008
    19 Jun 2008 $0.0700 0.00% Final 27 Jun 2008
    06 Dec 2007 $0.0095 0.00% Supplemental 14 Dec 2007
    06 Dec 2007 $0.0473 0.00% Interim 14 Dec 2007
    21 Jun 2007 $0.0124 0.00% Supplemental 29 Jun 2007
    21 Jun 2007 $0.0700 0.00% Final 29 Jun 2007
    23 Nov 2006 $0.0095 0.00% Supplemental 01 Dec 2006
    23 Nov 2006 $0.0540 0.00% Interim 01 Dec 2006
    19 Jun 2006 $0.0124 0.00% Supplemental 28 Jun 2006
    19 Jun 2006 $0.0700 0.00% Final 28 Jun 2006
    02 Dec 2005 $0.0095 0.00% Supplemental 09 Dec 2005
    02 Dec 2005 $0.0540 0.00% Interim 09 Dec 2005
    08 Jun 2005 $0.0102 0.00% Supplemental 17 Jun 2005
    08 Jun 2005 $0.0580 0.00% Final 17 Jun 2005
    24 Nov 2004 $0.0088 0.00% Supplemental 03 Dec 2004
    24 Nov 2004 $0.0500 0.00% Interim 03 Dec 2004
    14 Jun 2004 $0.0494 0.00% Supplemental 18 Jun 2004
    14 Jun 2004 $0.2800 0.00% Final 18 Jun 2004

    FPH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Fisher & Paykel Healthcare Corp Ltd

    Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) is among the world's major designers and manufacturers of respiratory devices. These include products and systems covering in-hospital respiratory care, acute care, and the treatment of obstructive sleep apnea.

    The New Zealand-based company earns around 42% of its revenue from the US market and around 30% in Europe. Its hospital products account for about 65% of its revenue with its at-home sleep apnea devices and other respiratory aids accounting for the rest.

    Fisher & Paykel invests more than 10% of its operating revenue into its own research and development and has thousands of patents and pending applications. The company has manufacturing facilities in both New Zealand and Mexico. 

    FPH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    04 Mar 2024 $22.75 $-0.08 -0.35% 151,975 $22.85 $23.08 $22.75
    01 Mar 2024 $22.83 $-0.16 -0.70% 230,049 $23.09 $23.17 $22.83
    29 Feb 2024 $22.99 $-0.45 -1.92% 421,534 $23.29 $23.43 $22.98
    28 Feb 2024 $23.44 $0.11 0.47% 185,135 $23.49 $23.58 $23.34
    27 Feb 2024 $23.33 $-0.06 -0.26% 121,420 $23.22 $23.47 $23.10
    26 Feb 2024 $23.39 $0.18 0.78% 138,255 $23.45 $23.45 $23.10
    23 Feb 2024 $23.21 $0.66 2.93% 256,944 $22.73 $23.32 $22.63
    22 Feb 2024 $22.55 $0.18 0.80% 97,321 $22.59 $22.84 $22.55
    21 Feb 2024 $22.37 $0.23 1.04% 215,214 $22.58 $22.77 $22.27
    20 Feb 2024 $22.14 $-0.24 -1.07% 198,790 $22.58 $22.62 $22.14
    19 Feb 2024 $22.38 $-0.31 -1.37% 178,383 $22.91 $22.91 $22.35
    16 Feb 2024 $22.69 $-0.01 -0.04% 377,838 $22.92 $22.96 $22.57
    15 Feb 2024 $22.70 $0.38 1.70% 234,562 $22.49 $22.83 $22.32
    14 Feb 2024 $22.32 $0.19 0.86% 183,813 $21.79 $22.41 $21.79
    13 Feb 2024 $22.13 $-0.29 -1.29% 236,023 $22.21 $22.37 $22.06
    12 Feb 2024 $22.42 $-0.61 -2.65% 233,231 $22.85 $22.85 $22.20
    09 Feb 2024 $23.03 $-0.05 -0.22% 257,267 $22.99 $23.14 $22.74
    08 Feb 2024 $23.08 $-0.22 -0.94% 210,106 $23.46 $23.46 $22.83
    07 Feb 2024 $23.30 $-0.09 -0.38% 261,275 $23.74 $23.74 $23.30
    06 Feb 2024 $23.39 $0.15 0.65% 419,277 $23.25 $23.62 $22.95

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Grenfell Daniell Non-Executive Director Nov 2001
    Mr Daniell was Managing Director and Chief Executive Officer of Fisher & Paykel Healthcare from November 2001 to March 2016. He was General Manager of Fisher & Paykel's medical division from 1990 to 2001 and previously held various technical management and product design roles within the company.
    Mr Lewis George Gradon Chief Executive OfficerManaging Director Apr 2016
    Mr Gradon became Managing Director & Chief Executive Officer in April 2016. Prior to that, he spent 15 years as Senior Vice President - Products & Technology, and six years as General Manager - Research and Development. During his 38-year tenure with Fisher & Paykel Healthcare he has held various engineering positions overseeing the development of our range of products as well the development of our manufacturing, quality, intellectual property, supply chain and clinical research functions.
    Mr Neville Mitchell Non-Executive Director Nov 2018
    -
    Dr Lisa Margaret McIntyre Non-Executive Director Oct 2021
    Ms McIntyre is a director of HCF Group, The University of Sydney, Studiosity, and Nanosonics. In addition to her current directorships, she has previously been a director of a range of health entities, including those in healthcare insurance, clinical service delivery and medical research and innovation. She spent 20 years as a senior strategy partner with LEK Consulting providing advice to companies in North America, Asia and Australia.
    Mr Donal Paul O'Dwyer Non-Executive Director Dec 2012
    Mr Mitchell was Chief Financial Officer and Company Secretary of Cochlear Limited between 1995 and 2017. He is a nonexecutive director of Sonic Healthcare and Q'Biotics Group and a former director of The Board of Tax, South East Sydney Local Health District, Osprey Medical and Sirtex Limited. Previously, he served on the New South Wales Medical Devices Fund, was Chairman of the Group of 100, and Chairman, Standing Committee (Accounting and Auditing), for the Australian Securities and Investments Commission.
    Ms Geraldine Celia McBride Non-Executive Director Aug 2013
    Ms McBride has been involved in the technology industry for 30 years and has a wealth of global experience. She has held senior executive roles at SAP AG and Dell Inc, and is a former President of SAP North America. She is a director of Sky Network Television Ltd and the founder and CEO of MyWave.
    Mr Scott Andrew St John Non-Executive DirectorNon-Executive Chairman Oct 2015
    Mr John is director of ANZ New Zealand Bank Limited, Mercury Limited, the NEXT Foundation and Fonterra Cooperative Group Limited. Scott was Chief Executive Officer of First NZ Capital from 2002 to 2017. He previously served as the Chancellor of the University of Auckland, Chairman of the Securities Industries Association and was a member of the Financial Markets Authority Establishment Board.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jun 2017
    Mr Greenwood is chair of Westpac New Zealand Limited, a director of a2 Milk Company Limited and Vulcan Steel Limited, a current trustee of the Auckland Writers Festival and served as a member of the New Zealand Takeovers Panel from 2007 to 2011.
    Dr Cather Simpson Non-Executive Director Jun 2022
    Dr Simpson is a professor of physics and chemical sciences at the University of Auckland and a partner at Pacific Channel, an early-stage investment company. She is a director of the International Society for Optics & Photonics (SPIE) and founder/director for Orbis Diagnostics. Dr Simpson also serves on the advisory boards of the Paihau-Robinson Research Institute at Victoria University and the New Zealand Product Accelerator.
    Mr Marcus James Driller Company SecretaryVice President - Corporate
    -
    Lyndal York Chief Financial Officer
    -
    Marcus James Driller Company SecretaryVice President - Corporate
    -
    Paul Shearer Senior Vice President - Sales & Marketing
    -
    Marcus Driller Vice President - Corporate
    -
    Nicola Talbot Vice President - Human Resources
    -
    Nicholas Fourie Vice President - Information & Communication Technology
    -
    Dr Andrew Somervell Vice President - Products & Technology
    -
    Brian Schultz Vice President - Quality & Regulatory Affairs
    -
    Jonti Rhodes Vice President - Supply Chain Facilities & Sustainability
    -
    Winston Fong Vice President - Surgical Technologies
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Nominees (New Zealand) Limited R601127393 78,877,291 13.60%
    HSBC Nominees (New Zealand) Limited R601127385 55,718,994 9.60%
    HSBC Custody Nominees (Australia) Limited 46,955,753 8.10%
    JPMorgan Chase Bank 39,490,847 6.80%
    JPMorgan Nominees Australia Pty Limited 34,669,791 6.00%
    Citicorp Nominees Pty Limited 34,071,336 5.90%
    BNP Paribas Nominees NZ Limited Bpss40 28,584,162 4.90%
    Citibank Nominees (NZ) Ltd 25,912,512 4.50%
    Custodial Services Limited 21,213,545 3.70%
    Tea Custodians Limited 15,341,886 2.70%
    New Zealand Superannuation Fund Nominees Limited 12,830,044 2.20%
    National Nominees Limited 10,530,010 1.80%
    Accident Compensation Corporation 9,144,701 1.60%
    Premier Nominees Limited 7,950,251 1.40%
    FNZ Custodians Limited 7,519,717 1.30%
    National Nominees New Zealand Limited 6,591,985 1.10%
    New Zealand Depository Nominee 5,695,871 1.00%
    JBWere (NZ) Nominees Limited 5,402,872 0.90%
    BNP Paribas Nominees NZ Limited 5,034,091 0.90%
    Public Trust 4,724,236 0.80%

    Profile

    since

    Note